"iDoctor – Medical Blog"

LITTLE FALLS, N.J. (MedPage Today) — The risk of tuberculosis is higher for patients receiving anti-tumor necrosis factor (anti-TNF) monoclonal antibody therapy than for those receiving soluble TNF receptor therapy for any indication, French researchers found.

This entry was posted on Friday, July 3rd, 2009 at 3:15 am and is filed under Health news. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.